| | |

School Supply Study Raises Mesothelioma Concerns

A group that tests common school supplies for toxins is warning parents to stay away from Playskool brand crayons sold at Dollar Tree stores because they could contain trace amounts of asbestos.

Even small amounts of asbestos have been linked to malignant mesothelioma, a rare but deadly cancer that can crop up decades after exposure.

The US Public Interest Research Group (PIRG), a non-governmental watchdog agency, says multiple tests of the green Playskool crayons found asbestos concentrations from .10% to .13%.

It is believed the asbestos may have come from the talc used in crayon manufacturing. The two types of mineral deposits typically lie close to each other and talc mines are often contaminated with asbestos.

Could Crayons Really Cause Mesothelioma?

Just how dangerous are asbestos-contaminated crayons?

As late as the 1970s, asbestos was a common component in thousands of building and insulation products and can still be found in most homes built before 1981.

Unless fibers of the mineral dust are inhaled or swallowed, the health threat to homeowners is low. The risk of mesothelioma rises quickly, however, when homeowners decide to launch a renovation project that disturbs deteriorating asbestos.

The danger with crayons is that children routinely put them in their mouths. If a child swallows even a few fibers of asbestos, it could trigger a cascade of physiological changes that could lead to a mesothelioma diagnosis in adulthood.

“It’s insane for us to be finding asbestos in kids’ products, whether it’s technically legal or not, and parents shouldn’t have to worry about this in 2018,” Dev Gowda, an author of the PIRG report, told the New York Times.

The PIRG has asked Dollar Tree to remove the contaminated crayons from the shelves and warn customers of the risk of mesothelioma and lung cancer.

Asbestos in Consumer Products

In an effort to reduce the risk for malignant mesothelioma, the  EPA and OSHA regulate the use of asbestos in the US, one of the few developed countries that has not banned the known carcinogen.

Unfortunately, some products still slip through the cracks and a number of asbestos-contaminated personal care products have made headlines recently amid mesothelioma fears:

  • Two dusting powder manufacturers have been sued (and many suits are still pending) by long-time users who claimed the products caused their peritoneal mesothelioma.
  • Last year, Claire’s was driven to pull several girls glitter makeup kits off the shelves after tests confirmed that they contained trace amounts of tremolite asbestos.
  • Earlier this year, the girls clothing store Justice announced a recall of eight different Just Shine makeup products because of asbestos concerns.

The risk of mesothelioma from consumer products is not expected to improve any time soon. The EPA introduced a proposal this summer to overturn a ban on new uses of asbestos.

Sources:

Safer School Supplies: Shopping Guide, US PIRG, August 7, 2018

Chokshi, Nirah, “Asbestos in a Crayon, Benzene in a Marker: A School Supply Study’s Toxic Results”, August 8, 2018, The New York Times

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • |

    Mesothelioma Case Shows Danger of Accidental Asbestos Exposure

    A mesothelioma case in Birmingham, England is a dramatic illustration of the very real danger of hidden asbestos. The widow of a physician who died of mesothelioma last year at the age of 51 claims her husband was exposed to asbestos just walking to and from his medical classes. Monisha Coelho believes that exposed asbestos insulation in the underground hallways that connect the University of Birmingham to buildings on the Queen Elizabeth Hospital campus triggered Dr. Ian Pardoe’s mesothelioma. In an article in the Birmingham Mail, Coelho explained how her husband decided how and where the deadly exposure had occurred. “Ian thought long and hard about where he might have come into contact with asbestos,” Coelho told the paper. “He…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…

  • | |

    New Mesothelioma Drug Kills Cancer Stem Cells

    Citing “significant enthusiasm within the mesothelioma community”, the manufacturers of a promising new mesothelioma drug say they have begun a major test of the drug in patients. Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. The designation, which is reserved for drugs that fight the rarest of diseases, helps pave the way for testing and faster approval, depending on the results of clinical trials. “Development of a drug that preferentially kills cancer stem cells is a promising approach, as many standard-of-care treatments have been shown to either have no…

  • | |

    Mesothelioma Study Finds New Treatment Target

    Immunotherapy, which involves reprogramming T-cells to find and attack cancer cells, is one of the fastest-growing areas of cancer research. One of the biggest challenges of immunotherapy is how to harness the power of T-cells against cancer without also turning them against healthy cells. A new study conducted in Switzerland and published in the Journal of Translational Medicine addressed the problem by reprogramming T-cells to recognize and attack mesothelioma cells that express a specific protein. Fibroblast Activation Protein (FAP) is expressed on the surface of tumor-associated fibroblast cells which are found in the connective tissue of mesothelioma tumors. FAP is also found in mesothelioma cells and may play a role in the start of cancer, as well as the growth…